Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mike Khouw Weighs In On SLV

On Friday's edition of CNBC's "Options Action," Mike Khouw answered a viewer's question about iShares Silver Trust (NYSE: SLV).

On Friday’s edition of CNBC’s “Options Action,” Mike Khouw answered a viewer’s question about iShares Silver Trust (NYSE:SLV). The viewer wanted to know if now is the right time to buy some call options in SLV and can it reach $30 by the end of the year.

Khouw likes silver fundamentally, but he finds $30 as a long way up for SLV. If we do get a rally in the ETF it will run into trouble at $26, he said. To make a bullish bet, he would use a zero-cost call spread risk reversal. He would sell a 10% out of the money put to finance the purchase of the $23/$26 call spread.

Total
0
Shares
Related Posts
Read More

Novartis Confirmed That It Has Been Contacted by the Swiss Competition Commission Regarding an Investigation Into the Assertion of a Patent Related to Dermatology Treatments

Novartis today confirms that it has been contacted by the Swiss Competition Commission (COMCO) which has initiated an investigation, in collaboration with the European Commission, into the assertion of a patent in the broader field of dermatology treatments. In connection with this investigation, COMCO representatives visited the company headquarters in Basel.

NVS